Cargando…
Blended Survival Curves: A New Approach to Extrapolation for Time-to-Event Outcomes from Clinical Trials in Health Technology Assessment
BACKGROUND: Survival extrapolation is essential in cost-effectiveness analysis to quantify the lifetime survival benefit associated with a new intervention, due to the restricted duration of randomized controlled trials (RCTs). Current approaches of extrapolation often assume that the treatment effe...
Autores principales: | Che, Zhaojing, Green, Nathan, Baio, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026162/ https://www.ncbi.nlm.nih.gov/pubmed/36314662 http://dx.doi.org/10.1177/0272989X221134545 |
Ejemplares similares
-
A Systematic Review of Methods to Incorporate External Evidence into Trial-Based Survival Extrapolations for Health Technology Assessment
por: Bullement, Ash, et al.
Publicado: (2023) -
Extrapolation of Survival Curves from Cancer Trials Using External Information
por: Guyot, Patricia, et al.
Publicado: (2016) -
Extrapolating Parametric Survival Models in Health Technology
Assessment: A Simulation Study
por: Gallacher, Daniel, et al.
Publicado: (2020) -
An Evaluation of Survival Curve Extrapolation Techniques Using
Long-Term Observational Cancer Data
por: Vickers, Adrian
Publicado: (2019) -
Impact of limited sample size and follow-up on single event survival extrapolation for health technology assessment: a simulation study
por: Beca, Jaclyn M., et al.
Publicado: (2021)